| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 5.96 | 0.20 (+3.47%) | 1.75 - 6.90 | 23.5 thousand (Below Avg) |
Market data as of 4:00PM 05/17/13. Quotes are delayed by at least 15 min.
| Open | 5.83 |
|---|---|
| Previous Close | 5.76 |
| Day's Range | 5.75 - 5.96 |
| Market Cap | 64.6M |
| Avg Volume (10 Day) | 44.3K |
| Price/Earnings (Trailing 12 Mo.) | -- |
| Earnings Per Share (Trailing 12 Mo.) | -0.71 |
| Dividend Yield | No Dividend |


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Performed well consistently? | Fail |
|---|---|
| Avoids excess debt? | Fail |
| Converting sales to profits? | Fail |
| Shareholder's money handled rationally? | Neutral |
| Increased shareholder value? | Neutral |
| Consistently increased owner earnings? | Fail |
| Sells at 25% discount to intrinsic value? | Fail |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Pays a cash dividend? | Fail |
|---|---|
| Room to increase dividends? | Fail |
| Increased earnings over time? | Fail |
| Borrows within reasonable limits? | Fail |
| Stock is undervalued? | Fail |
| Have investors caught on? | Fail |
| Has support of institutional investors? | Fail |
| Has sufficient liquidity? | Pass |
iCAD’s Xoft Intraoperative Radiation Therapy System Featured at American Society of Breast Surgeons Conference
Business Wire - Friday 05/03/2013 9:20 AM ET
iCAD Reports First Quarter Financial Results
Business Wire - Monday 04/29/2013 4:05 PM ET
iCAD to Present at the 12th Annual Needham Healthcare Conference
Business Wire - Wednesday 04/24/2013 9:00 AM ET
iCAD Announces Poster Presentation of Xoft System to Treat Skin Cancer Highlighted at 2013 American Brachytherapy Society Annual Meeting
Business Wire - Thursday 04/18/2013 1:30 PM ET
| ICAD | Industry Range | |
|---|---|---|
| Revenue Growth (1yr) | 8.00% | |
| Net Income Growth (1yr) | -- | |
| Total Debt/Equity | 0.55 | |
| LT Debt/Equity | 0.55 | |
| Earnings Yield | -- | |
| Price/Sales | 2.16 |
| Company | Last | Change |
|---|---|---|
| Cimatron Ltd | 7.02 | +0.86% |
| Attunity Ltd | 5.37 | +2.87% |
| Evolving Systems Inc | 6.51 | +1.24% |
| Image Sensing Systems Inc | 5.17 | -0.96% |
| Intelligent Systems Corp | 1.40 | +6.68% |
Data is delayed by at least 15 min.